UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a)
of the Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒
Filed by a party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement |
| ☒ | Definitive Additional Materials |
| ☐ | Soliciting Material under §240.14a-12 |
Turtle Beach Corporation
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
| ☒ | No fee required |
| ☐ | Fee paid previously with preliminary materials |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
Turtle Beach Corporation
44 South Broadway, 4th Floor
White Plains, New York 10601
Supplement No. 1 to
Definitive Proxy Statement dated May 26, 2023
for the Annual Meeting of Stockholders to be held on July 6, 2023
On May 26, 2023, Turtle Beach Corporation (the “Company”) filed its definitive Proxy Statement (“Proxy Statement”) relating to the solicitation of proxies by the Company in connection with its 2023 Annual Meeting of Stockholders to be held on July 6, 2023, at 12:00 p.m. ET (the “Annual Meeting”). The purpose of this supplement to the Proxy Statement is to correct an inadvertent typographical error in the Proxy Statement.
Shares Underlying Full Value Awards
The ITEM 3 – Approval of Amendment to 2013 Stock-Based Incentive Compensation Plan (as Amended) in our Proxy Statement contained an inadvertent typographical error on page 26 with respect to our reported shares underlying full value awards amount reported, under the section Purpose of Share Reserve Increase. The figure was originally reported as 1,808,711, and it should have been reported as 1,080,711. The table from page 26 containing this figure is hereby restated as follows:
| Shares underlying outstanding stock options (#) |
Weighted average exercise price per share ($) |
Weighted average remaining term |
Shares underlying Full Value Awards |
Shares available for future grant | ||||
| 1,528,686 |
7.66 | 5.55 | 1,080,711 | 6,880 |